First Trust NYSE Arca Biotechnology Index Fund
FBT
307 hedge funds and large institutions have $1.65B invested in First Trust NYSE Arca Biotechnology Index Fund in 2026 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 104 increasing their positions, 74 reducing their positions, and 24 closing their positions.
1,148% more call options, than puts
Call options by funds: $4.26M | Put options by funds: $341K
142% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 24
132% more capital invested
Capital invested by funds: $713M → $1.65B (+$942M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
41% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 74
19.07% more ownership
Funds ownership: 53.83% → 72.9% (+19%)
10% more funds holding
Funds holding: 279 → 307 (+28)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$726M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$49.2M |
| 3 |
Morgan Stanley
New York
|
+$27.5M |
| 4 |
NP
Nilsine Partners
Greenwood Village,
Colorado
|
+$18.6M |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$15.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFGP
Stonebridge Financial Group (Pennsylvania)
Wormleysburg,
Pennsylvania
|
-$14.7M |
| 2 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$2.89M |
| 3 |
BFG
Berger Financial Group
Plymouth,
Minnesota
|
-$2.18M |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$1.9M |
| 5 |
SA
SFI Advisors
Montclair,
New Jersey
|
-$1.85M |
FBT Hedge Fund Activity: Q1 2026 in Review
307 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q1 2026, worth a combined $1.65B — up 132% from $713M a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new FBT positions and 24 closed out — a net gain of 34 holders — while 104 added to existing stakes and 74 trimmed.
The largest buyer was First Trust Advisors, adding an estimated $726M. The largest seller was Stonebridge Financial Group (Pennsylvania), exiting entirely with an estimated $14.7M sold.
- 307 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q1 2026, up from 279 in Q4 2025.
- Funds reported $1.65B of First Trust NYSE Arca Biotechnology Index Fund stock for Q1 2026, up 132% quarter-over-quarter.
- 58 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q1 2026 and 24 closed out, a net change of +34 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q1 2026 was First Trust Advisors, an estimated $726M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q1 2026 was Stonebridge Financial Group (Pennsylvania), an estimated $14.7M sold.
Based on aggregated 13F filings for Q1 2026.